Cluster of Differentiation 86 (also known as CD86 and B7-2) is a protein expressed on antigen-presenting cells that provides costimulatory signals necessary for T cell activation and survival. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD86 works in tandem with CD80 to prime T cells.
The CD86gene encodes a type I membrane protein that is a member of the immunoglobulin superfamily.Alternative splicing results in two transcript variants encoding different isoforms. Additional transcript variants have been described, but their full-length sequences have not been determined.
↑Chen C, Gault A, Shen L, Nabavi N (May 1994). "Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule". Journal of Immunology. 152 (10): 4929–36. PMID7513726.
Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M (April 2010). "New genetic associations detected in a host response study to hepatitis B vaccine". Genes and Immunity. 11 (3): 232–8. doi:10.1038/gene.2010.1. PMID20237496.
Pan XM, Gao LB, Liang WB, Liu Y, Zhu Y, Tang M, Li YB, Zhang L (July 2010). "CD86 +1057 G/A polymorphism and the risk of colorectal cancer". DNA and Cell Biology. 29 (7): 381–6. doi:10.1089/dna.2009.1003. PMID20380573.
Dalla-Costa R, Pincerati MR, Beltrame MH, Malheiros D, Petzl-Erler ML (August 2010). "Polymorphisms in the 2q33 and 3q21 chromosome regions including T-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus". Human Immunology. 71 (8): 809–17. doi:10.1016/j.humimm.2010.04.001. PMID20433886.
Kim SH, Lee JE, Kim SH, Jee YK, Kim YK, Park HS, Min KU, Park HW (December 2009). "Allelic variants of CD40 and CD40L genes interact to promote antibiotic-induced cutaneous allergic reactions". Clinical and Experimental Allergy. 39 (12): 1852–6. doi:10.1111/j.1365-2222.2009.03336.x. PMID19735272.
Liu Y, Liang WB, Gao LB, Pan XM, Chen TY, Wang YY, Xue H, Zhang LS, Zhang L (November 2010). "CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease". Human Immunology. 71 (11): 1141–6. doi:10.1016/j.humimm.2010.08.007. PMID20732370.
Ma XN, Wang X, Yan YY, Yang L, Zhang DL, Sheng X, Liu XM, Huang H, Dai J, Zhong YJ, Liao LC (June 2010). "Absence of association between CD86 +1057G/A polymorphism and coronary artery disease". DNA and Cell Biology. 29 (6): 325–8. doi:10.1089/dna.2009.0987. PMID20230296.
Ishizaki Y, Yukaya N, Kusuhara K, Kira R, Torisu H, Ihara K, Sakai Y, Sanefuji M, Pipo-Deveza JR, Silao CL, Sanchez BC, Lukban MB, Salonga AM, Hara T (April 2010). "PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis". Human Genetics. 127 (4): 411–9. doi:10.1007/s00439-009-0781-z. PMID20066438.
Chang TT, Kuchroo VK, Sharpe AH (2002). "Role of the B7-CD28/CTLA-4 pathway in autoimmune disease". Current Directions in Autoimmunity. 5: 113–30. doi:10.1159/000060550. PMID11826754.
Grujic M, Bartholdy C, Remy M, Pinschewer DD, Christensen JP, Thomsen AR (August 2010). "The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus". Journal of Immunology. 185 (3): 1730–43. doi:10.4049/jimmunol.0903894. PMID20601595.
Quaranta MG, Mattioli B, Giordani L, Viora M (November 2006). "The immunoregulatory effects of HIV-1 Nef on dendritic cells and the pathogenesis of AIDS". FASEB Journal. 20 (13): 2198–208. doi:10.1096/fj.06-6260rev. PMID17077296.
Schuurhof A, Bont L, Siezen CL, Hodemaekers H, van Houwelingen HC, Kimman TG, Hoebee B, Kimpen JL, Janssen R (June 2010). "Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls". Pediatric Pulmonology. 45 (6): 608–13. doi:10.1002/ppul.21229. PMID20503287.